Co-expression of IL-15 enhances anti-neuroblastoma effectivity of a tyrosine hydroxylase-directed DNA vaccination in mice (scientific article published in PLoS ONE)

DNA immunization: ubiquitination of a viral protein enhances cytotoxic T-lymphocyte induction and antiviral protection but abrogates antibody induction

Q24671114

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

Q27860475

IL-15Ralpha recycles and presents IL-15 In trans to neighboring cells

Q28214975

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

Q29547865

Unmodified self antigen triggers human CD8 T cells with stronger tumor reactivity than altered antigen

Q33322422

Plasmid-encoded interleukin-15 receptor alpha enhances specific immune responses induced by a DNA vaccine in vivo

Q33690988

DNA vaccines: developing new strategies against cancer

Q33756622

Combined IL-15/IL-15Ralpha immunotherapy maximizes IL-15 activity in vivo

Q33760403

Co-administration of a plasmid DNA encoding IL-15 improves long-term protection of a genetic vaccine against Trypanosoma cruzi

Q33847435

High dose of plasmid IL-15 inhibits immune responses in an influenza non-human primates immunogenicity model

Q33987553

Antitumor vaccination: where we stand.

Q34080782

Vaccines for cancer prevention: a practical and feasible approach to the cancer epidemic

Q34180316

Translating tumor antigens into cancer vaccines

Q34484042

PD-1 blockade augments anti-neuroblastoma immune response induced by anti-GD2 antibody ch14.18/CHO.

Q50445794

Safety and immunogenicity of tyrosinase DNA vaccines in patients with melanoma.

Q51972264

Coimmunization with an optimized IL-15 plasmid results in enhanced function and longevity of CD8 T cells that are partially independent of CD4 T cell help.

Q51991024

Development of a xenogeneic DNA vaccine program for canine malignant melanoma at the Animal Medical Center.

Q54239486

Increasing gene expression in yeast by fusion to ubiquitin.

Q54730106

A phase I clinical study of vaccination of melanoma patients with dendritic cells loaded with allogeneic apoptotic/necrotic melanoma cells. Analysis of toxicity and immune response to the vaccine and of IL-10 -1082 promoter genotype as predictor of d

Q59216407

Cytokine-facilitated priming of CD8+ T cell responses by DNA vaccination

Q73037501

Cutting edge: transpresentation of IL-15 by bone marrow-derived cells necessitates expression of IL-15 and IL-15R alpha by the same cells

Q81040823

Neuroblastoma

Q88730901

Converting IL-15 to a superagonist by binding to soluble IL-15R{alpha}

Q34694913

Cancer immunotherapy and breaking immune tolerance: new approaches to an old challenge.

Q34859794

Functional bioassays for immune monitoring of high-risk neuroblastoma patients treated with ch14.18/CHO anti-GD2 antibody

Q35255233

Neuroblastoma: molecular pathogenesis and therapy

Q35564199

Pediatric neuroblastomas: genetic and epigenetic 'danse macabre'.

Q35617266

Vector Design for Improved DNA Vaccine Efficacy, Safety and Production

Q35826665

Inducing autoimmune disease to treat cancer

Q35976297

Identification of epitope mimics recognized by CTL reactive to the melanoma/melanocyte-derived peptide MART-1(27-35)

Q36367223

Dendritic cells are responsible for the capacity of CpG oligodeoxynucleotides to act as an adjuvant for protective vaccine immunity against Leishmania major in mice

Q36371330

DNA-Salmonella enterica serovar Typhimurium primer-booster vaccination biases towards T helper 1 responses and enhances protection against Leishmania major infection in mice

Q36445502

Signals required for programming effector and memory development by CD8+ T cells

Q36528952

Development of TLR9 agonists for cancer therapy

Q36809776

Current progress of DNA vaccine studies in humans

Q37103923

Safety and immunologic effects of IL-15 administration in nonhuman primates

Q37352474

MTS dye based colorimetric CTLL-2 cell proliferation assay for product release and stability monitoring of interleukin-15: assay qualification, standardization and statistical analysis

Q37449716

Immunotherapeutic applications of IL-15.

Q38050510

Interleukin-15 in gene therapy of cancer.

Q38060229

Recommendations for the standardization of bone marrow disease assessment and reporting in children with neuroblastoma on behalf of the International Neuroblastoma Response Criteria Bone Marrow Working Group.

Q39041489

Tumor targeting of the IL-15 superagonist RLI by an anti-GD2 antibody strongly enhances its antitumor potency

Q39203683

Salmonella SL7207 application is the most effective DNA vaccine delivery method for successful tumor eradication in a murine model for neuroblastoma

Q39207345

A rationally designed tyrosine hydroxylase DNA vaccine induces specific antineuroblastoma immunity

Q40068180

Targeted interleukin-2 therapy for spontaneous neuroblastoma metastases to bone marrow

Q41080467

Detection of neuroblastoma cells in bone marrow and peripheral blood at diagnosis by the reverse transcriptase-polymerase chain reaction for tyrosine hydroxylase mRNA.

Q41339590

Tumor mRNA-transfected dendritic cells stimulate the generation of CTL that recognize neuroblastoma-associated antigens and kill tumor cells: immunotherapeutic implications

Q43105000

Xenogeneic immunization with human tyrosine hydroxylase DNA vaccines suppresses growth of established neuroblastoma.

Q43293834

Low-dose aspirin delays an inflammatory tumor progression in vivo in a transgenic mouse model of neuroblastoma

Q43460633

Real-time RT-PCR of tyrosine hydroxylase to detect bone marrow involvement in advanced neuroblastoma.

Q44310221

Tyrosine hydroxylase-based DNA-vaccination is effective against murine neuroblastoma

Q46833083

Recent Advances in Vaccine Technologies

Q47318218

Vaccination with minigenes encoding for novel 'self' antigens are effective in DNA-vaccination against neuroblastoma.